See more : Teamo Productions HQ Limited (TPHQ.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Natural Health Trends Corp. (NHTC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Natural Health Trends Corp., a leading company in the Specialty Retail industry within the Consumer Cyclical sector.
You may be interested
- NITTAN Corporation (6493.T) Income Statement Analysis – Financial Results
- Nanjing Chervon Auto Precision Technology Co., Ltd (603982.SS) Income Statement Analysis – Financial Results
- Media Asia Group Holdings Limited (8075.HK) Income Statement Analysis – Financial Results
- Connected IO Limited (CIO.AX) Income Statement Analysis – Financial Results
- MIRC Electronics Limited (MIRCELECTR.BO) Income Statement Analysis – Financial Results
Natural Health Trends Corp. (NHTC)
About Natural Health Trends Corp.
Natural Health Trends Corp., a direct-selling and e-commerce company, provides personal care, wellness, and lifestyle products under the NHT Global brand. The company offers wellness products, including liquid, encapsulated, tableted, and powder dietary and nutritional supplements, as well as vitamins and minerals; and herbal products comprising herbal supplements. It also provides beauty products, such as age-defying and hydrating cleansers, creams, lotions, serums, and toners; and lifestyle products, which include weight management and energy enhancing supplements. In addition, the company offers home appliances; daily products, such as oral care, hair care, and body care; and home appliances products. It sells its products directly to consumers, as well as through an e-commerce retail platform in the United States, Canada, Cayman Islands, Mexico, Peru, Hong Kong, Taiwan, China, Singapore, Malaysia, Thailand, Vietnam, South Korea, Japan, India, Russia, Kazakhstan, and Europe. The company was formerly known as Florida Institute of Massage Therapy, Inc. and changed its name to Natural Health Trends Corp. in June 1993. Natural Health Trends Corp. was incorporated in 1988 and is headquartered in Tsim Sha Tsui, Hong Kong.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 43.92M | 49.13M | 60.01M | 62.07M | 77.61M | 191.91M | 197.56M | 287.73M | 264.86M | 124.59M | 52.53M | 37.51M | 31.16M | 23.58M | 30.74M | 45.81M | 76.50M | 133.43M | 194.47M | 133.23M | 62.89M | 39.66M | 24.79M | 8.32M | 15.27M | 1.19M | 6.99M | 7.22M |
| Cost of Revenue | 11.18M | 12.66M | 15.01M | 16.99M | 20.10M | 39.37M | 38.65M | 54.90M | 54.10M | 26.98M | 12.55M | 9.69M | 8.17M | 6.97M | 9.53M | 12.68M | 20.29M | 33.07M | 44.75M | 29.32M | 12.52M | 7.39M | 5.88M | 2.05M | 4.27M | 454.37K | 2.87M | 4.44M |
| Gross Profit | 32.75M | 36.47M | 45.00M | 45.08M | 57.51M | 152.54M | 158.92M | 232.83M | 210.76M | 97.61M | 39.98M | 27.83M | 22.99M | 16.61M | 21.21M | 33.13M | 56.21M | 100.36M | 149.73M | 103.90M | 50.36M | 32.27M | 18.92M | 6.27M | 11.00M | 736.75K | 4.12M | 2.78M |
| Gross Profit Ratio | 74.56% | 74.23% | 74.99% | 72.63% | 74.10% | 79.49% | 80.44% | 80.92% | 79.57% | 78.34% | 76.11% | 74.18% | 73.78% | 70.44% | 69.01% | 72.32% | 73.48% | 75.22% | 76.99% | 77.99% | 80.08% | 81.36% | 76.30% | 75.41% | 72.06% | 61.85% | 58.98% | 38.46% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 16.01M | 16.00M | 17.85M | 18.21M | 27.22M | 31.31M | 31.69M | 43.25M | 36.02M | 19.69M | 11.63M | 9.42M | 9.05M | 9.80M | 13.89M | 17.17M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17.64M | 18.46M | 7.72M | 3.28M | 7.64M | 3.41M |
| Selling & Marketing | 18.41M | 20.75M | 25.58M | 26.20M | 35.55M | 87.50M | 115.32M | 168.30M | 162.62M | 76.68M | 35.69M | 25.14M | 11.86M | 8.67M | 11.60M | 17.65M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 34.42M | 36.74M | 43.42M | 44.41M | 62.77M | 118.81M | 115.32M | 168.30M | 162.62M | 76.68M | 35.69M | 25.14M | 20.91M | 18.47M | 25.48M | 34.82M | 69.62M | 114.00M | 152.78M | 101.68M | 43.84M | 28.77M | 17.64M | 18.46M | 7.72M | 3.28M | 7.64M | 3.41M |
| Other Expenses | 0.00 | 872.00K | -61.00K | 821.00K | 1.43M | 789.00K | 367.00K | -59.00K | -84.00K | -184.00K | -32.00K | -39.00K | 298.00K | 1.21M | 1.32M | 1.46M | 11.82M | -1.41M | 59.03M | 39.26M | -50.00M | 0.00 | 0.00 | 0.00 | 10.40M | 0.00 | 543.21K | 22.00K |
| Operating Expenses | 34.42M | 36.74M | 43.42M | 44.41M | 62.77M | 118.81M | 115.86M | 168.69M | 162.89M | 76.79M | 35.75M | 25.18M | 21.21M | 19.69M | 26.80M | 36.28M | 81.44M | 112.60M | 152.78M | 101.68M | -6.16M | 28.77M | 17.64M | 18.46M | 18.12M | 3.28M | 8.18M | 3.43M |
| Cost & Expenses | 45.60M | 49.40M | 58.43M | 61.40M | 82.87M | 158.18M | 154.50M | 223.59M | 216.98M | 103.77M | 48.30M | 34.87M | 29.38M | 26.66M | 36.33M | 48.96M | 101.73M | 145.66M | 197.53M | 131.00M | 6.36M | 36.16M | 23.51M | 20.51M | 22.39M | 3.73M | 11.05M | 7.88M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.00K | 9.00K | 36.00K | 107.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16.00K | 18.00K | 2.55M | 2.42M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.10M | 1.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 164.00K | 1.38M | 1.46M | 1.94M | 2.15M | 424.00K | 536.00K | 394.00K | 263.00K | 105.00K | 66.00K | 45.00K | 298.00K | 1.21M | 1.32M | 1.46M | 1.85M | 2.11M | 1.47M | 1.30M | 531.94K | 469.70K | 90.58K | 364.40K | 374.15K | 549.67K | 567.67K | 244.57K |
| EBITDA | -1.51M | -66.00K | 1.87M | 1.08M | -4.87M | 34.16M | 43.60M | 64.53M | 48.14M | 20.93M | 4.29M | 2.69M | 2.08M | -1.28M | -2.59M | 472.00K | -23.37M | -10.12M | -1.83M | 3.52M | 6.11M | 437.00K | 1.37M | -11.82M | -6.74M | -1.99M | -3.41M | -413.86K |
| EBITDA Ratio | -3.43% | -0.13% | 3.12% | 1.74% | -4.00% | 17.80% | 22.07% | 22.43% | 18.18% | 16.80% | 8.17% | 7.17% | 6.69% | -7.88% | -13.77% | -3.47% | -15.13% | -8.49% | -0.24% | 2.48% | 90.63% | 7.76% | 5.65% | -142.21% | -43.72% | -167.12% | -48.73% | -5.73% |
| Operating Income | -1.67M | -270.00K | 1.57M | 669.00K | -5.26M | 33.73M | 43.06M | 64.14M | 47.88M | 20.82M | 4.22M | 2.65M | 1.78M | -3.08M | -5.59M | -3.18M | -25.22M | -12.23M | -3.05M | 2.22M | 56.52M | 3.50M | 1.28M | -12.55M | -7.12M | -2.54M | -4.06M | -658.43K |
| Operating Income Ratio | -3.80% | -0.55% | 2.62% | 1.08% | -6.78% | 17.58% | 21.80% | 22.29% | 18.08% | 16.71% | 8.04% | 7.05% | 5.72% | -13.06% | -18.18% | -6.95% | -32.97% | -9.17% | -1.57% | 1.67% | 89.88% | 8.83% | 5.17% | -150.86% | -46.61% | -213.27% | -58.00% | -9.12% |
| Total Other Income/Expenses | 2.42M | 872.00K | -61.00K | 821.00K | 1.43M | 789.00K | 367.00K | -59.00K | -84.00K | -184.00K | -32.00K | -39.00K | 344.00K | 583.00K | -875.00K | -226.00K | 143.00K | 946.00K | -277.00K | 137.00K | -1.00K | -199.00K | -79.95K | 9.08K | -67.18K | 1.25M | -1.14M | -231.11K |
| Income Before Tax | 745.00K | 602.00K | 1.51M | 1.49M | -5.60M | 34.52M | 43.43M | 64.08M | 47.79M | 20.64M | 4.19M | 2.61M | 2.13M | -2.50M | -6.46M | -3.41M | -25.08M | -11.29M | -3.96M | 2.36M | 6.24M | 4.10M | 1.20M | -10.67M | -7.25M | -1.29M | -5.20M | -889.54K |
| Income Before Tax Ratio | 1.70% | 1.23% | 2.52% | 2.40% | -7.21% | 17.99% | 21.98% | 22.27% | 18.04% | 16.56% | 7.98% | 6.95% | 6.83% | -10.59% | -21.02% | -7.44% | -32.79% | -8.46% | -2.04% | 1.77% | 9.92% | 10.34% | 4.85% | -128.24% | -47.50% | -108.13% | -74.37% | -12.32% |
| Income Tax Expense | 177.00K | 289.00K | 425.00K | 647.00K | 14.00K | 3.49M | 19.85M | 8.99M | 552.00K | 266.00K | 102.00K | -24.00K | -298.00K | -27.00K | -78.00K | 456.00K | 200.00K | 182.00K | 1.59M | 663.00K | 860.00K | -4.10M | -1.20M | 10.67M | 7.25M | 1.29M | 2.52M | 231.11K |
| Net Income | 568.00K | 313.00K | 1.09M | 843.00K | -5.61M | 31.04M | 23.58M | 55.09M | 47.24M | 20.37M | 4.09M | 2.63M | 2.31M | -2.45M | -6.34M | -3.86M | -25.29M | -11.46M | -5.50M | 1.24M | 5.38M | 4.10M | 1.20M | -10.67M | -7.25M | -1.29M | -7.73M | -889.54K |
| Net Income Ratio | 1.29% | 0.64% | 1.81% | 1.36% | -7.23% | 16.17% | 11.93% | 19.15% | 17.84% | 16.35% | 7.78% | 7.01% | 7.40% | -10.38% | -20.63% | -8.44% | -33.05% | -8.59% | -2.83% | 0.93% | 8.55% | 10.34% | 4.85% | -128.24% | -47.50% | -108.13% | -110.48% | -12.32% |
| EPS | 0.05 | 0.03 | 0.10 | 0.08 | -0.52 | 2.75 | 2.10 | 4.84 | 3.84 | 1.67 | 0.36 | 0.24 | 0.21 | -0.23 | -0.63 | -0.40 | -2.96 | -1.42 | -0.79 | 0.22 | 1.03 | 0.60 | 0.44 | -111.27 | -100.28 | -58.27 | -805.12 | -317.35 |
| EPS Diluted | 0.05 | 0.03 | 0.10 | 0.07 | -0.52 | 2.74 | 2.09 | 4.83 | 3.82 | 1.61 | 0.36 | 0.23 | 0.21 | -0.23 | -0.63 | -0.40 | -2.96 | -1.42 | -0.79 | 0.18 | 0.83 | -11.00 | -98.00 | -111.27 | -100.28 | -58.27 | -805.12 | -317.35 |
| Weighted Avg Shares Out | 11.44M | 11.36M | 11.02M | 10.63M | 10.87M | 11.30M | 11.25M | 11.38M | 12.30M | 12.13M | 11.15M | 10.94M | 10.70M | 10.51M | 10.14M | 9.68M | 8.56M | 8.08M | 6.93M | 5.58M | 4.61M | 2.90M | 1.07M | 95.89K | 72.33K | 22.10K | 9.60K | 2.80K |
| Weighted Avg Shares Out (Dil) | 11.46M | 11.42M | 11.42M | 11.42M | 10.87M | 11.32M | 11.27M | 11.41M | 12.37M | 12.60M | 11.33M | 11.23M | 10.83M | 10.51M | 10.14M | 9.68M | 8.56M | 8.08M | 6.93M | 6.82M | 5.69M | 2.90M | 1.07M | 95.89K | 72.33K | 22.10K | 9.60K | 2.80K |
Natural Health Trends Reports Third Quarter 2020 Financial Results
– Maintained profitability with third quarter earnings per share improving to $0.06 – Achieved positive third quarter sales momentum in markets outside of Hong Kong – Strong balance sheet with ample liquidity – Declared a quarterly cash dividend of $0.20...
Natural Health Trends to Report Third Quarter 2020 Financial Results on November 4th
HONG KONG, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness, and “quality of life” products under the NHT Global brand, today announced the...
Condor Hospitality Signs Settlement Agreement With NHT Parties With Respect to Terminated Merger Agreement
Condor Hospitality Trust, Inc. (NYSE American: CDOR) (the
Merger Arbitrage Mondays - Condor Hospitality Terminates Merger Agreement With NHT Operating Partnership
Merger activity slowed down last week with no new deals announced. Two potential deals announced.
Natural Health Trends Corp. (NHTC) Management on Q2 2020 Results - Earnings Call Transcript
Natural Health Trends Corp. (NASDAQ:NHTC) Q2 2020 Earnings Conference Call August 5, 2020 11:30 ET Company Participants Kim Orlando - Investor Relations Chris Sharng - President Scott Davidson - Chief Financial Officer Conference Call Participants Presentation Operator Welcome to the...
Ruthven Towers to hit the market June 2021
Phase one of Ruthven Towers, the residential development that sparked concerns over unit prices that were more expensive than those normally set by the National Housing Trust, NHT, will soon be placed on the market. The NHT subsequently returned to...
A suivre aujourd'hui... IPSEN
(AOF) - Ipsen va rejoindre la collaboration clinique d'Exelixis et Roche et participera au financement des études pivotales internationales de phase III Contact-01 et Contact-02. L'essai Contact-01 évalue
IPSEN rejoint une collaboration clinique pour évaluer le cabozantinib
(AOF) - Ipsen va rejoindre la collaboration clinique d'Exelixis et Roche et participera au financement des études pivotales internationales de phase III Contact-01 et Contact-02. L'essai Contact-01 évalue
Source: https://incomestatements.info
Category: Stock Reports